KR960702315A - 혈관 차단 치료에서의 헤모글로빈의 치료적 용도 (Therapeutic Use of Hemoglobin in the Treatment of Blood Vessel Blockage) - Google Patents

혈관 차단 치료에서의 헤모글로빈의 치료적 용도 (Therapeutic Use of Hemoglobin in the Treatment of Blood Vessel Blockage)

Info

Publication number
KR960702315A
KR960702315A KR1019950705304A KR19950705304A KR960702315A KR 960702315 A KR960702315 A KR 960702315A KR 1019950705304 A KR1019950705304 A KR 1019950705304A KR 19950705304 A KR19950705304 A KR 19950705304A KR 960702315 A KR960702315 A KR 960702315A
Authority
KR
South Korea
Prior art keywords
hemoglobin
treatment
blood vessel
therapeutic use
vessel blockage
Prior art date
Application number
KR1019950705304A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1995/003788 external-priority patent/WO1995026195A1/en
Application filed filed Critical
Publication of KR960702315A publication Critical patent/KR960702315A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/41—Porphyrin- or corrin-ring-containing peptides
    • A61K38/42—Haemoglobins; Myoglobins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1019950705304A 1994-03-28 1995-11-27 혈관 차단 치료에서의 헤모글로빈의 치료적 용도 (Therapeutic Use of Hemoglobin in the Treatment of Blood Vessel Blockage) KR960702315A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21853694A 1994-03-28 1994-03-28
US08/350,204 US6458762B1 (en) 1994-03-28 1994-12-02 Therapeutic use of hemoglobin for preserving tissue viability and reducing restenosis
PCT/US1995/003788 WO1995026195A1 (en) 1994-03-28 1995-03-27 Therapeutic use of hemoglobin in the treatment of blood vessel blockage

Publications (1)

Publication Number Publication Date
KR960702315A true KR960702315A (ko) 1996-04-27

Family

ID=22815501

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950705304A KR960702315A (ko) 1994-03-28 1995-11-27 혈관 차단 치료에서의 헤모글로빈의 치료적 용도 (Therapeutic Use of Hemoglobin in the Treatment of Blood Vessel Blockage)

Country Status (3)

Country Link
US (2) US6458762B1 (ko)
KR (1) KR960702315A (ko)
ZA (1) ZA952519B (ko)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5854209A (en) 1995-03-23 1998-12-29 Biopure Corporation Method for oxygenating tissue having reduced red blood cell flow
JP2000511449A (ja) * 1996-06-03 2000-09-05 マリンクロット・インコーポレイテッド 超音波装置および対照試薬を較正する方法およびそのための装置
US7798815B2 (en) * 2002-04-03 2010-09-21 University Of The West Indies Computer-controlled tissue-based simulator for training in cardiac surgical techniques
US8986253B2 (en) 2008-01-25 2015-03-24 Tandem Diabetes Care, Inc. Two chamber pumps and related methods
US8408421B2 (en) 2008-09-16 2013-04-02 Tandem Diabetes Care, Inc. Flow regulating stopcocks and related methods
EP2334234A4 (en) 2008-09-19 2013-03-20 Tandem Diabetes Care Inc DEVICE FOR MEASURING THE CONCENTRATION OF A SOLVED SUBSTANCE AND CORRESPONDING METHOD
US9248093B2 (en) * 2009-06-11 2016-02-02 Becton, Dickinson And Company Catheter locking solution having antimicrobial and anticoagulation properties
US20110152770A1 (en) 2009-07-30 2011-06-23 Tandem Diabetes Care, Inc. Infusion pump system with disposable cartridge having pressure venting and pressure feedback
US9180242B2 (en) 2012-05-17 2015-11-10 Tandem Diabetes Care, Inc. Methods and devices for multiple fluid transfer
US9173998B2 (en) 2013-03-14 2015-11-03 Tandem Diabetes Care, Inc. System and method for detecting occlusions in an infusion pump
WO2019018403A1 (en) 2017-07-18 2019-01-24 Virtech Bio, Llc BLOOD SUBSTITUTES COMPRISING HEMOGLOBIN AND METHODS OF MAKING

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1479268A (en) 1973-07-05 1977-07-13 Beecham Group Ltd Pharmaceutical compositions
DE2449885C3 (de) 1974-10-21 1980-04-30 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Verfahren zur Herstellung von chemisch modifizierten haltbaren Hämoglobinpräparaten sowie das nach diesem Verfahren hergestellte modifizierte Hämoglobinpräparat
US4061736A (en) 1975-02-02 1977-12-06 Alza Corporation Pharmaceutically acceptable intramolecularly cross-linked, stromal-free hemoglobin
US4053590A (en) 1975-02-27 1977-10-11 Alza Corporation Compositions of matter comprising macromolecular hemoglobin
US4640835A (en) 1981-10-30 1987-02-03 Nippon Chemiphar Company, Ltd. Plasminogen activator derivatives
US4757052A (en) 1982-09-03 1988-07-12 Markov Angel K Method of preserving blood
US4529719A (en) * 1983-05-04 1985-07-16 Tye Ross W Modified crosslinked stroma-free tetrameric hemoglobin
FR2551660B1 (fr) 1983-09-13 1986-11-14 Centre Nat Rech Scient Hemoglobine modifiee chimiquement, sa preparation, solutions aqueuses en contenant et leur utilisation
GB8328917D0 (en) 1983-10-28 1983-11-30 Fisons Plc Blood substitute
FR2555589B1 (fr) 1983-11-30 1986-05-16 Choay Sa Nouveaux derives du dextrane a activites anticoagulante en anti-inflammatoire, leur procede de preparation et utilisation de ces derives en tant qu'anticoagulants et en tant que substituts du plasma sanguin
USRE34271E (en) 1984-06-27 1993-06-01 University Of Iowa Research Foundation Production of alpha-alpha cross-linked hemoglobins in high yield
US4600531A (en) 1984-06-27 1986-07-15 University Of Iowa Research Foundation Production of alpha-alpha cross-linked hemoglobins in high yield
GB8430252D0 (en) 1984-11-30 1985-01-09 Beecham Group Plc Compounds
US4798824A (en) 1985-10-03 1989-01-17 Wisconsin Alumni Research Foundation Perfusate for the preservation of organs
US5194590A (en) 1986-06-20 1993-03-16 Northfield Laboratories, Inc. Acellular red blood cell substitute
US4826811A (en) 1986-06-20 1989-05-02 Northfield Laboratories, Inc. Acellular red blood cell substitute
US5464814A (en) 1986-06-20 1995-11-07 Northfield Laboratories, Inc. Acellular red blood cell substitute
WO1988003408A1 (en) 1986-11-10 1988-05-19 Biopure Corporation Extra pure semi-synthetic blood substitute
US5084558A (en) 1987-10-13 1992-01-28 Biopure Corporation Extra pure semi-synthetic blood substitute
CA1312009C (en) 1986-11-10 1992-12-29 Carl W. Rausch Extra pure semi-synthetic blood substitute
US4866096A (en) 1987-03-20 1989-09-12 Air Products And Chemicals, Inc. Stable fluorochemical aqueous emulsions
US5268500A (en) 1987-06-15 1993-12-07 Montefiore Medical Center Compound, composition and method for the reduction of lipids the modification of the affinity of hemoblogin for oxygen and the prevention of platelet aggregation
US4994444A (en) 1987-07-31 1991-02-19 The Trustees Of Columbia In The City Of New York Macromolecules for sealing capillary endothelial junctions
US4988515A (en) 1988-01-28 1991-01-29 The Regents Of The Univ. Of Calif. Cardioplegic solution
IL87707A (en) 1988-09-08 1994-06-24 Technion Inst For Research And Hemoglobin-based blood substitute substantially similar to human blood and method for preparation thereof
IL87708A (en) 1988-09-08 1994-04-12 Technion Inst For Research And Hemoglobin-based blood substitute possessing a colloid oncotic pressure substantially similar to human blood and method for the preparation thereof
FR2640141B1 (fr) 1988-12-14 1993-04-16 Merieux Inst Conjugues macromoleculaires d'hemoglobine, leur procede de preparation et leurs applications
US5173426A (en) 1989-10-06 1992-12-22 Yale University DNAs encoding genetically engineered low oxygen affinity mutants of human hemoglobin
US5370870A (en) 1989-10-06 1994-12-06 Genentech, Inc. Method for protection against reactive oxygen species
US5386014A (en) 1989-11-22 1995-01-31 Enzon, Inc. Chemically modified hemoglobin as an effective, stable, non-immunogenic red blood cell substitute
US5432191A (en) 1990-02-12 1995-07-11 The Center For Innovative Technology Allosteric hemoglobin modifiers to decrease oxygen affinity in blood
US5248785A (en) 1990-02-12 1993-09-28 Virginia Commonwealth University Using allosteric hemoglobin modifiers to decrease oxygen affinity in blood
CA2036770C (en) 1990-02-26 2003-09-09 Jeffrey P. Whitten Inhibitors of nitric oxide biosynthesis
US5306508A (en) 1990-06-22 1994-04-26 The Regents Of The University Of California Red blood cell surrogate
FR2680369B1 (fr) 1991-08-14 1993-11-05 Pasteur Merieux Serums Vaccins Derives d'hemoglobine humaine, leur procede de preparation, produits en derivant et utilisation de ces derives et produits.
CA2122717C (en) 1991-11-08 2003-07-15 David C. Anderson Hemoglobins as drug delivery agents
US5334706A (en) 1992-01-30 1994-08-02 Baxter International Administration of low dose hemoglobin to increase perfusion
WO1993016720A1 (en) 1992-02-20 1993-09-02 The Regents Of The University Of California Inhibition of bacterial endotoxin
CA2074852A1 (en) 1992-07-29 1994-01-30 Ehud Ilan Organ perfusion hemoglobins

Also Published As

Publication number Publication date
US6458762B1 (en) 2002-10-01
ZA952519B (en) 1995-12-18
US5877146A (en) 1999-03-02

Similar Documents

Publication Publication Date Title
CY2007001I1 (el) Φαρμακευτικο σκευασμα για χρηση στη θεραπεια του διαβητη
DE69529245T2 (de) Nicht-invasiver Blutanalysator
DE69635364D1 (de) Blutfilter und extrakorporaler Kreislauf
EP0844008A4 (en) DEVICE FOR USE IN THE LASER TREATMENT OF BIOLOGICAL TISSUE (ITS VARIANTS)
DK25087A (da) Endoskop til ledning af udsendte lysstraaler og tilbrug ved medicinsk behandling
HUP9774641A2 (en) Gel for treatment of skin diseases and for disinfection of the skin
DE69522470D1 (de) Blutgefässprothese
EP0378692A4 (en) Catheter for medical treatment
KR960702315A (ko) 혈관 차단 치료에서의 헤모글로빈의 치료적 용도 (Therapeutic Use of Hemoglobin in the Treatment of Blood Vessel Blockage)
DE3680364D1 (de) Katheter fuer anwendung in blutgefaessen.
IL129144A0 (en) Use of 1-hydroxy-2-pyridones for the treatment of skin diseases
DE69829217D1 (de) Vorrichtung zur therapeutischen behandlung von blutgefässen
IL119757A0 (en) Finger-pressure functioning health-aid instrument for improving blood circulation in the human body
FI973185A0 (fi) Melatoniinin käyttö lääkeriippuvuudesta kärsivien potilaiden hoitoon
ZA968054B (en) Therapeutic use of hemoglobin in promoting wound healing
FI952170A0 (fi) Koagulaatiota edistävää aktiivista ainetta sisältävä stabiili valmisteveren koagulaatiosairauksien hoitamiseksi
IS5324A (is) (S) 2-Metýlamínó-2-fenýl-n-bútýl 3,4,5-trímetoxý-bensóat, notkun þess til meðferðar á langvinnum sársauka
ZA9610584B (en) Use of rc-9 in diagnosis and treatment of proliferative arterial disease
DE59811703D1 (de) Medizinischer oder dentalmedizinischer Behandlungsstuhl
DE9418730U1 (de) Patientenliege
GB9216360D0 (en) Treatment of blood
IT9019347A1 (it) Filtro monouso particolarmente per impieghi in ambito medico chirurgico
DE29713580U1 (de) Medizinischer oder dentalmedizinischer Behandlungsstuhl
DE29603099U1 (de) Patienten-Nachttisch mit Safe
AU2001248355A1 (en) The use of anticoagulant agents in the extracorporeal treatment of blood

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid